Critical limb ischemia: Does long-term patency matter?

Vascular Medicine

Volumn 15, Issue 6, 2010, Pages 439-441

  Jaffery, Zehra ^a   Grant, Arthur G ^a   White, Christopher J ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

outcome assessment (health care); peripheral artery disease

Indexed keywords

AGED; ANGIOPLASTY; ARTICLE; CLINICAL ARTICLE; FOLLOW UP; HUMAN; LEG ULCER; LIMB ISCHEMIA; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; HUMANS; ISCHEMIA; LEG ULCER; LOUISIANA; LOWER EXTREMITY; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; WOUND HEALING;

EID: 78650660122     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10384534     Document Type: Article

References (10)

1. Arnold TE, Kerstein MD Secondary distal extension of infrainguinal bypass: long-term limb and patient survival. Ann Vasc Surg 2000 ; 14: 450-456.
2. Brumberg RS, Back MR, Armstrong PA, et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg 2007 ; 46: 1160-1166.
3. Faglia E., Mantero M., Caminiti M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002 ; 252: 225-232.
4. Adam DJ, Beard JD, Cleveland T., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005 ; 366: 1925-1934.
5. Gargiulo M., Maioli F., Ceccacci T., et al. What's next after optimal infrapopliteal angioplasty? Clinical and ultrasonographic results of a prospective single-center study. J Endovasc Ther 2008 ; 15: 363-369.
6. Grant AG, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv 2008 ; 71: 108-111.
7. Feiring AJ, Krahn M., Nelson L., Wesolowski A., Eastwood D., Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 2010 ; 55: 1580-1589.
8. Biondi-Zoccai GG, Sangiorgi G., Lotrionte M., et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009 ; 16: 251-260.
9. Siablis D., Karnabatidis D., Katsanos K., et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009 ; 20: 1141-1150.
10. Dick F., Diehm N., Galimanis A., Husmann M., Schmidli J., Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 2007 ; 45: 751-761.